State Farm Mutual Automobile Insurance Co. v. Amazon.com, Inc.

District Court, D. Delaware·Decided September 11, 2024·No. 1:22-cv-01447·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

STATE FARM MUTUAL AUTOMOBILE ) INSURANCE CO., ) ) Plaintiff, ) ) v. ) Civil Action No. 22-1447-CJB ) AMAZON.COM, INC. and ) AMAZON.COM SERVICES LLC, ) ) Defendants. )

MEMORANDUM ORDER At Wilmington, Delaware this 11th day of September, 2024. WHEREAS, the Court has reviewed Plaintiff State Farm Mutual Automobile Insurance Company’s (“Plaintiff”) “Motion to Strike Portions of Amazon’s Opening Invalidity Report Containing Obviousness Combinations Not Elected by Amazon Pursuant to the Scheduling Order[,]” (“Motion”), (D.I. 209), and the briefing related thereto, (D.I. 210; D.I. 212; D.I. 213), and heard argument on the Motion on September 9, 2024; NOW, THEREFORE, IT IS HEREBY ORDERED as follows: 1. Paragraph 6(h)(iv) of the Scheduling Order provides that “[b]y February 28, 2024, Defendants shall assert no more than six prior art references against each patent and not more than a total of 30 references. . . . For purposes of this Final Election of Asserted Prior Art [“Final Election”], each obviousness combination counts as a separate prior art reference” (“paragraph 6(h)(iv)”). (D.I. 34 at 4) On February 28, 2024 (“February 28”), Defendants sent Plaintiff an e-mail identifying their Final Election; Defendants listed six prior art obviousness combinations for each asserted patent pursuant to paragraph 6(h)(iv); on the same date, Defendants also served their Final Invalidity Contentions, which identified the same six selected obviousness combinations for each asserted patent (the “six combinations”). (D.I. 210, ex. 2 at 6-7; id., ex. 3 at 16-22)1 On June 27, 2024, Defendants served the expert report of Dr. Benjamin B. Bederson regarding invalidity (the “Bederson Report”). (Id., ex. 1) In the Bederson Report, Dr. Bederson asserts that the ECSP patents are invalid in light of numerous different subsets of

the identified six combinations. More specifically (and for example), instead of asserting that the '235 patent is invalid in light of the six combinations, Dr. Bederson asserts that the '235 patent is invalid in light of 11 different obviousness combinations (the “additional combinations”)— combinations that do not identically match any of the previously-identified six combinations. (Id., ex. 1 at 69-225 & Appendix B at 1-2)2 With the Motion, Plaintiff requests that the Court strike the portions of the Bederson Report referencing the additional combinations (i.e., any combinations beyond the six combinations per patent that had been selected by Defendants on February 28), and permit Defendants to serve an amended report that removes the additional combinations. (D.I. 210 at 1)3 2. As a threshold matter, the parties dispute the standard that applies to the instant

1 There are six asserted patents: United States Patent Nos. 11,056,235 (the “'235 patent”), 11,107,581 (the “'581 patent”), 11,114,203 (the “'203 patent”), 11,393,585 (the “'585 patent”), 10,825,318 (the “'318 patent”) and 11,094,180 (the “'180 patent”). The '235, '581, '203 and '585 patents will be referred to as the “ECSP patents” and the '318 and '180 patents will be referred to as the “SPHERES patents.”

2 While Dr. Bederson used the phrase “and/or” with respect to certain of the additional combinations (which could allow for them to have even greater breadth), during oral argument, Plaintiff’s counsel acknowledged that Dr. Bederson confirmed during his deposition that “and/or” really just means “and.”

3 The Motion also asserted that for the SPHERES patents, Dr. Bederson had discussed numerous combinations that were different than the six combinations per patent that Defendants had selected on February 28—due to Dr. Bederson’s use of the phrase “and/or” in his proffered combinations. (D.I. 210 at 2) However, in light of Dr. Bederson’s subsequent deposition testimony, in which he confirmed that “and/or” means “and,” the instant dispute is now solely focused on the ECSP patents. Motion. Plaintiff asserts that with the Bederson Report, Defendants violated paragraph 6(h)(iv) of the Scheduling Order and thus, pursuant to Federal Rule of Civil Procedure 16, Defendants must show good cause for asserting the additional combinations in the Bederson Report. (Id. at 2) Meanwhile, Defendants argue that Federal Rule of Civil Procedure 37 and the Pennypack

factors should apply to the parties’ dispute. (D.I. 212 at 4-5) The Court sides with Plaintiff here. If after serving the Final Election, Defendants had thereafter served an amended Final Election asserting all of the same additional combinations that are now found in the Bederson Report, then such an amendment would have clearly violated paragraph 6(h)(iv). And here, the Bederson Report accomplishes the exact same thing, just in a slightly different format. In other words, with the Bederson Report, Defendants are in fact asserting “more than six prior references against each patent” (references that are different than those selected in their “Final Election”)— just what paragraph 6(h)(iv) prohibits. (D.I. 34 at 4) Because service of the Bederson Report amounts to a violation of the Court’s Scheduling Order, Defendants must therefore show good cause to support the inclusion of these additional combinations. Fed. R. Civ. P. 16(b)(4); see

also Chervon (HK) Ltd. v. One World Techs., Inc., Civil Action No. 19-1293-GBW, 2023 WL 2372938, at *3 & n.3 (D. Del. Mar. 6, 2023) (applying the good cause standard to a dispute regarding defendants’ untimely amended final invalidity contentions).4 In determining whether a party has demonstrated good cause, courts first consider the diligence of the party seeking to modify the scheduling order. See, e.g., Brit. Telecommc’ns PLC v. IAC/InterActiveCorp, Civil Action No. 18-366-WCB, 2020 WL 3047989, at *2 (D. Del. June 8, 2020); GlaxoSmithKline LLC v. Glenmark Pharms. Inc., Civil Action No. 14-877-LPS-CJB, 2016 WL 7319670, at *1 (D.

4 A court may exclude expert opinion and testimony pursuant to Fed. R. Civ. P. 16(f), which permits a court to impose such sanctions if, inter alia, a party “fails to obey a scheduling [order] or other pretrial order.” Fed. R. Civ. P. 16(f)(1)(C). Del. Dec 15, 2016). If that party has not been diligent, the inquiry ends (as good cause has not been demonstrated). See, e.g., Allergan, Inc. v. Revance Therapeutics, Inc., Civil Action No. 21- 1411-RGA, 2024 WL 2254771, at *3-4 (D. Del. May 17, 2024).5 3. On the record before the Court, Defendants have not shown good cause for

asserting the additional combinations in the Bederson Report. In order for Defendants to demonstrate diligence, Defendants would need to show that they could not have known that they needed to earlier assert the additional references. But the record before the Court simply does not indicate this (as Defendants do not really seem to try to make that argument).6 Although Defendants attempt to argue that the additional combinations do not present any new theories since they constitute a subset of previously disclosed combinations, (D.I. 212 at 2-3), the Court cannot agree.7 Defendants’ violation of the Scheduling Order in asserting the additional

Free access — add to your briefcase to read the full text and ask questions with AI

State Farm Mutual Automobile Insurance Co. v. Amazon.com, Inc., (D. Del. 2024).

State Farm Mutual Automobile Insurance Co. v. Amazon.com, Inc. (State Farm Mutual Automobile Insurance Co. v. Amazon.com, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.